ストックスクリーナーアプリを入手
5.12
5.01%
-0.27
アフターアワーズ：
5.18
0.06
+1.17%
Protara Therapeutics Inc (TARA) 最新ニュース
Why analysts recommend Protara Therapeutics Inc. (1KPA) stock2026 world cup usa national team semifinals young talents counter attacking expert forecast statistical analysis - Улправда
FDA grants breakthrough therapy designation to Protara’s LM treatment By Investing.com - Investing.com Nigeria
Protara Therapeutics slumps 12%, raises $75M equity at $5.75 per share - MSN
Protara Therapeutics updates on TARA-002 development - The Pharma Letter
Protara, CeriBell rise on FDA breakthrough designations (TARA:NASDAQ) - Seeking Alpha
Protara Therapeutics (TARA) Gains FDA Designations for TARA-002 - GuruFocus
FDA grants breakthrough therapy designation to Protara’s LM treatment - Investing.com
Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations - The Manila Times
FDA fast-tracks new cell therapy for kids with rare lymphatic disorder - Stock Titan
Protara Therapeutics’ TARA-002 Study: A Potential Game-Changer for Lymphatic Malformations - MSN
Levels Update: How forex fluctuations impact Protara Therapeutics Inc 1KPA stock2025 Historical Comparison & Fast Entry and Exit Trade Plans - moha.gov.vn
Assenagon Asset Management S.A. Invests $1.34 Million in Protara Therapeutics, Inc. $TARA - Defense World
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients on Wednesday, December 3, 2025 - Sahm
Sentiment Watch: Can Protara Therapeutics Inc stock attract ESG capital inflows2025 EndofYear Setup & Weekly High Potential Stock Alerts - moha.gov.vn
Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Resistance Check: Is Protara Therapeutics Inc. (1KPA) stock attractive for dividend growth2025 Technical Patterns & Fast Entry Momentum Trade Alerts - moha.gov.vn
Why Protara Therapeutics Inc. stock could outperform in 2025Quarterly Risk Review & Stepwise Trade Execution Plans - Улправда
Can Protara Therapeutics Inc. stock attract ESG capital inflowsPrice Action & Daily Chart Pattern Signal Reports - DonanımHaber
Protara Therapeutics raises $86.3 million in offering - MSN
Protara Therapeutics Raises $86.3 Million in Offering - TipRanks
Protara Therapeutics, Inc. (NASDAQ: TARA) details $86.3M equity raise from stock sale - Stock Titan
What analysts say about Protara Therapeutics Inc stockSwing Trading Ideas & Get Alerts Before Market Turns Ugly - earlytimes.in
Acorn Capital Advisors LLC Acquires 472,315 Shares of Protara Therapeutics, Inc. $TARA - MarketBeat
Protara Therapeutics, Inc. $TARA is Velan Capital Investment Management LP's 4th Largest Position - MarketBeat
Protara Therapeutics completes $75 million stock offering - MSN
Protara Announces Closing of $75 Million Public Offering - The Manila Times
Protara announces proposed public offering - MSN
Protara Therapeutics Completes $75 Million Stock Offering - TipRanks
Protara therapeutics raises $75 million in public offering - Investing.com
Protara Therapeutics Closes $75 Million Public Offering - marketscreener.com
Protara therapeutics raises $75 million in public offering By Investing.com - Investing.com India
Protara Therapeutics (Nasdaq: TARA) closes $75M stock sale of 13.0M shares at $5.75 - Stock Titan
HC Wainwright & Co. reiterates Protara Therapeutics (TARA) buy recommendation - MSN
Is Protara Therapeutics Inc a good long term investmentOptions Trading Strategies & High Return Trading Strategies - earlytimes.in
Protara Therapeutics Inc. (TARA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Protara Therapeutics: Stock Offer Takes the Spotlight - StocksToTrade
Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025 - ts2.tech
Protara Prices $75 Mln Offering To Advance TARA-002 And Broader Pipeline - Nasdaq
Biotech co Protara slides on $75 mln share sale - TradingView — Track All Markets
Protara Therapeutics Shares Sink 16% After $75 Mln Public Offering - Nasdaq
Protara Therapeutics (Nasdaq: TARA) prices 13,043,479-share, $75M public deal - Stock Titan
Protara Therapeutics (TARA) Launches $75M Public Offering - GuruFocus
Protara Therapeutics Prices $75 Million Share Offering - marketscreener.com
12 Health Care Stocks Moving In Friday's Pre-Market SessionAkanda (NASDAQ:AKAN), CDT Equity (NASDAQ:CDT) - Benzinga
Will Protara Therapeutics Inc. (1KPA) stock benefit from sector leadershipJuly 2025 Price Swings & Accurate Trade Setup Notifications - Newser
Protara Therapeutics prices $75 million public offering By Investing.com - Investing.com Nigeria
TARA Stock Offering Priced at Lower End of Target Range - GuruFocus
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):